Alimentary Pharmacology & Therapeutics

Review article: the diagnosis and treatment of haematinic deficiency in gastrointestinal disease
pp. 687-698(12)
Authors: Pawson,; Mehta,

Increased bone resorption in patients with Crohn's disease
pp. 699-705(7)
Authors: Robinson,; Iqbal,; Abrams,; Al-Azzawi,; Mayberry,

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis
pp. 707-715(9)
Authors: Kruis,; Brandes,; Schreiber,; Theuer,; Krakamp,; Schütz,; Otto,; Lorenz-Mayer,; Ewe,; Judmaier,

Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
pp. 717-723(7)
Authors: Moreno-Monteagudo,; Fernández-Bermejo,; García-Buey,; Sanz,; Iacono,; García-Monzón,; Borque,; Moreno-Otero,

One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer
pp. 725-730(6)
Authors: Sung,; Leung,; Ling,; Yung,; Chan,; Lee,; Cheng,; Chung,

Short-term low-dose pantoprazole-based triple therapy for cure of Helicobacter pylori infection in duodenal ulcer patients
pp. 731-734(4)
Authors: Pazzi,; Scagliarini,; Gamberini,; Matarese,; Rizzo,; Gullini,

Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease
pp. 735-740(6)
Authors: Meining,; Kiel,; Stolte,

Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori
pp. 741-745(5)
Authors: Harris,; Misiewicz,; Bardhan,; Levi,; O'morain,; Cooper,; Kerr,; Dixon,; Langworthy,; Piper,

Effects of cholinergic agents on anorectal physiology
pp. 747-754(8)
Authors: Siproudhis,; Bellissant,; Juguet,; Allain,; Bretagne,; Gosselin,

The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia
pp. 755-759(5)
Authors: Besherdas,; Leahy,; Mason,; Harbord,; Epstein,

The influence of cisapride on gastric tone and the perception of gastric distension
pp. 761-766(6)
Authors: Tack,; Broeckaert,; Coulie,; Janssens,

Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclooxygenase (COX)-1 and COX-2 during gastric adaptation to aspirin damage in rats
pp. 767-777(11)
Authors: Konturek,; Brzozowski,; Pierzchalski,; Kwiecien,; Pajdo,; Hahn,

Relationship between fundic endocrine cells and gastric acid secretion in hypersecretory duodenal ulcer diseases
pp. 779-788(10)
Authors: Annibale,; Aprile,; Ferraro,; Marignani,; Angeletti,; D′ambra,; Caruana,; Bordi,; Fave, G. Delle

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre study
pp. 789-795(7)
Authors: Dekkers,; Beker,; Thjodleifsson,; Gabryelewicz,; Bell,; Humphries,

Trends in prescribing H₂-receptor antagonists and proton pump inhibitors in primary care
pp. 797-805(9)
Authors: Martin,; Lim,; Kerry,; Hilton,